RT @sitcancer: #JITC Research: Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity https://t.co/LheS0RiLCG https:/…
RT @sitcancer: #JITC Research: Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity https://t.co/LheS0RiLCG https:/…
Excellent way to inhibit Tregs (https://t.co/v0qad90xfB), which probably contribute to more inhibition of the anti-tumor response since they directly attack anti-tumor T cells.
RT @sitcancer: #JITC Research: Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity https://t.co/LheS0RiLCG https:/…
RT @sitcancer: #JITC Research: Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity https://t.co/LheS0RiLCG https:/…
#JITC Research: Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity https://t.co/LheS0RiLCG https://t.co/ymR8nEWIBG
#JITC Research: Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity https://t.co/LheS0RiLCG https://t.co/KuB4myl0xf
Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity #Secarna $IONS $AKCA $WVE $BPTH $RHHBY $GLAXO $AZN #antisense #gapmer #oligonucleotides #ASO $DVAX $IDRA $MGNK #checkmatepharma @ArtKrieg https://t.co/hLtf6Za0i4 https://t.co/n
RT @sitcancer: New #JITC Research: Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity https://t.co/LheS0RiLCG htt…
RT @sitcancer: New #JITC Research: Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity https://t.co/LheS0RiLCG htt…
RT @sitcancer: New #JITC Research: Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity https://t.co/LheS0RiLCG htt…
New #JITC Research: Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity https://t.co/LheS0RiLCG https://t.co/3SkFrXdMdy